Barclays
CGON icon

Barclays’s CG Oncology CGON Stock Holding History

Barclays’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$778K Sell
11,499
-176,011
-94% -$9.97M ﹤0.01% 2902
2025
Q4 		$7.79M Buy
187,510
+33,555
+22% +$1.39M ﹤0.01% 1883
2025
Q3 		$6.2M Sell
153,955
-192,545
-56% -$5.6M ﹤0.01% 2026
2025
Q2 		$9.01M Buy
346,500
+253,961
+274% +$6.12M ﹤0.01% 1659
2025
Q1 		$2.27M Sell
92,539
-8,718
-9% -$245K ﹤0.01% 2541
2024
Q4 		$2.9M Buy
101,257
+10,737
+12% +$367K ﹤0.01% 2610
2024
Q3 		$3.42M Buy
90,520
+69,523
+331% +$2.44M ﹤0.01% 2404
2024
Q2 		$663K Buy
20,997
+4,644
+28% +$161K ﹤0.01% 2857
2024
Q1 		$718K Buy
+16,353
New +$668K ﹤0.01% 3353

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM